[
  {
    "secCode": "9267",
    "filerName": "Ｇｅｎｋｙ　ＤｒｕｇＳｔｏｒｅｓ株式会社",
    "docID": "S100UCX9",
    "docPdfURL": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100UCX9.pdf",
    "yahooURL": "https://finance.yahoo.co.jp/quote/9267.T",
    "periodEnd": "2024年6月期",
    "characteristic": "３ 【事業の内容】当社は、持株会社として傘下グループ会社の経営管理及びそれに附帯する業務を行っております。",
    "stockPrice": 2744.808,
    "netSales": 184860000000.0,
    "employees": 1661,
    "operatingIncome": 9015000000.0,
    "operatingIncomeRate": 4.876663420967218,
    "depreciation": 5566000000.0,
    "ebitda": 14581000000.0,
    "ebitdaMargin": 7.887590609109596,
    "marketCapitalization": 41670577132.8,
    "per": 13.2,
    "ev": 36264577132.8,
    "evPerEbitda": 2.487111798422605,
    "pbr": 1.7907033487516393,
    "bps": 1532.81,
    "equity": 46681000000.0,
    "debt": 490000000.0,
    "outstandingShares": 15181600,
    "netIncome": 6324000000.0,
    "eps": 207.94,
    "cash": 5896000000.0,
    "retrievedDate": "2025-06-29"
  }
]